Cytokinetics Announces Positive Data from a Phase IIA Clinical Trial of Tirasemtiv in patients with Myasthenia Gravis

[at noodls] – Myasthenia Gravis Is the Third Disease in which Single Doses of Tirasemtiv Have Produced Potentially Clinically Meaningful Pharmacodynamic Effects in Phase II Trials South San Francisco, CA – November … more

View todays social media effects on CYTK

View the latest stocks trending across Twitter. Click to view dashboard